Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

President Donald Trump’s exemption of pharmaceuticals from “reciprocal” tariffs limited the declines of biopharma stocks as ...

Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

US private equity firm Vance Street Capital has expanded its life sciences manufacturing platform with the acquisition of ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

Government needs to take steps at home and in the European Union to ensure continued competitiveness of the sector ...

Belfast’s Diaceutics has agreed a contract with the new US licence holder for the oncology precision medicine BIZENGRI, which ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $2.79, a high ...

Plenty of money changed hands in pharma M&A during March, with the biggest deal a $6.7 billion merger between Mallinckrodt ...

Pharmaceuticals are exempt from the cascade of 'Liberation Day' tariffs revealed by President Donald Trump – for now – but ...